Immune thrombocytopenia

Common Name(s)

Immune thrombocytopenia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Immune thrombocytopenia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Immune thrombocytopenia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Immune thrombocytopenia" returned 194 free, full-text research articles on human participants. First 3 results:

Irinotecan-induced immune thrombocytopenia.
 

Author(s): Barry C Mirtsching, James N George, Richard H Aster, Brian R Curtis

Journal: Am. J. Med. Sci.. 2014 Feb;347(2):167-9.

 

Last Updated: 29 Jan 2014

Go To URL
Recombinant human thrombopoietin in combination with cyclosporin A as a novel therapy in corticosteroid-resistant primary immune thrombocytopenia.
 

Author(s): Zhong-Guang Cui, Xin-Guang Liu, Ping Qin, Ming Hou, Shao-Ling Wu, Jun Peng, Hong-Guo Zhao, Hong-Yi Wang, Chun-Ting Zhao

Journal: Chin. Med. J.. 2013 Nov;126(21):4145-8.

 

The management of patients with refractory immune thrombocytopenia (ITP) is challenging, as there is no standard treatment option. The aim of this study was to investigate the efficacy of recombinant human thrombopoietin (rhTPO) in combination with cyclosporin A (CsA) for the management ...

Last Updated: 15 Nov 2013

Go To URL
Association between acute myelogenous leukemia and thrombopoietin receptor agonists in patients with immune thrombocytopenia.
 

Author(s): Yasuo Oshima, Koichiro Yuji, Tetsuya Tanimoto, Yasushi Hinomura, Arinobu Tojo

Journal: Intern. Med.. 2013 ;52(19):2193-201.

 

The development of myeloid malignancies is a concern when administering thrombopoietin receptor (or the myeloproliferative leukemia virus proto-oncogene product, MPL) agonists. Progression from myelodysplastic syndrome (MDS) to acute myelogenous leukemia [AML, 9 (6.12%) AML patients ...

Last Updated: 3 Oct 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Immune thrombocytopenia" returned 49 free, full-text review articles on human participants. First 3 results:

Approach to the diagnosis and management of drug-induced immune thrombocytopenia.
 

Author(s): Donald M Arnold, Ishac Nazi, Theodore E Warkentin, James W Smith, Lisa J Toltl, James N George, John G Kelton

Journal: Transfus Med Rev. 2013 Jul;27(3):137-45.

 

Drug-induced immune thrombocytopenia (DITP) is a challenging clinical problem that is under-recognized, difficult to diagnose and associated with severe bleeding complications. DITP may be caused by classic drug-dependent platelet antibodies (eg, quinine); haptens (eg, penicillin); ...

Last Updated: 26 Jul 2013

Go To URL
Chinese contribution to immune thrombocytopenia: the pathogenesis-oriented treatment.
 

Author(s): Ping Qin, Jun Peng, Ming Hou

Journal: Chin. Med. J.. 2013 Jul;126(13):2564-9.

 

Last Updated: 4 Jul 2013

Go To URL
Immune thrombocytopenia.
 

Author(s): Gaurav Kistangari, Keith R McCrae

Journal: Hematol. Oncol. Clin. North Am.. 2013 Jun;27(3):495-520.

 

Immune thrombocytopenia (ITP) is a common hematologic disorder characterized by isolated thrombocytopenia. ITP presents as a primary or a secondary form. ITP may affect individuals of all ages, with peaks during childhood and in the elderly, in whom the age-specific incidence of ITP ...

Last Updated: 29 May 2013

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 12 Jun 2013

Go to URL

Last Updated: 30 May 2013

Go to URL
An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia
 

Status: Recruiting

Condition Summary: Immune Thrombocytopenia

 

Last Updated: 10 Jun 2014

Go to URL